Abstract
Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens.
Claims
Information currently unavailable.
Owners (US)
-
The Regents Of The University Of California
(Jun 28 2005)
Explore more patents:
Applicants
-
Univ California
Explore more patents:
Inventors
CPC Classifications
US Classifications
-
514/9.000
Explore more patents:
-
530/317.000
Explore more patents:
-
536/23.500
Explore more patents:
Download PDF
Document Preview
Document History
- Publication: Dec 8, 2005
-
Application:
Nov 5, 2004
US 98214504 A
-
Priority:
Nov 5, 2004
US 98214504 A
-
Priority:
May 6, 2003
US 0314106 W
-
Priority:
May 6, 2002
US 14164502 A
-
Priority:
Apr 18, 2002
US 0212353 W
-
Priority:
Apr 18, 2001
US 28485501 P